Related Experiment Video
Updated: Jul 23, 2025

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
Revascularisation Options for Chronic Limb Threatening Ischaemia in Diabetes: Implications From Two Recent Trials
Jaime H X Lin1,2, Nikolaos Papanas3, Hany Zayed4
1Diabetes and Diabetic Foot, King's College NHS Foundation Trust, London, UK.
Insights
For chronic limb-threatening ischaemia (CLTI), recent trials suggest an individualized revascularization strategy is best. Optimal management requires a multidisciplinary approach for patients with diabetes and CLTI.
Area of Science:
- Vascular Surgery
- Cardiovascular Medicine
- Diabetic Foot Care
Background:
- Chronic limb-threatening ischaemia (CLTI) is a severe manifestation of peripheral arterial disease (PAD), leading to high risks of amputation, mortality, and reduced quality of life.
- Current international guidelines advocate for timely revascularization and optimal medical therapy to enhance limb perfusion in CLTI patients.
- A lack of consensus exists regarding the optimal initial treatment strategy between open bypass surgery (BS) and endovascular therapy (EV) for CLTI, causing clinical uncertainty.
Purpose of the Study:
- To provide insights into the optimal revascularization strategy for CLTI by analyzing data from the BEST-CLI and BASIL-2 trials.
- To inform the diabetic foot multidisciplinary team about the latest findings in CLTI management.
- To highlight the need for personalized treatment approaches in CLTI.
Main Methods:
- Analysis of patient cohorts from two major trials: BEST-CLI (Best Endovascular versus Best Surgical Therapy in patients with CLI) and BASIL-2 (Bypass versus Angioplasty for Severe Ischaemia of the leg).
- Inclusion of participants with diverse medical and physical frailty levels.
- Evaluation of revascularization outcomes based on individual patient characteristics and comorbidities.
Main Results:
- While definitive conclusions are pending, the trials offer immediate clinical relevance for CLTI management.
- Findings underscore the necessity of tailoring revascularization strategies to individual patient factors, including comorbidities, risk factors, disease severity, conduit availability, surgical risks, and procedural access.
- The trials provide valuable data for clinicians managing patients with CLTI, particularly those with diabetes.
Conclusions:
- An individualized revascularization strategy is crucial for optimizing outcomes in CLTI patients.
- Early referral to a specialist multidisciplinary team is essential for comprehensive CLTI care in diabetic patients.
- Comprehensive management should include wound care, infection control, offloading, glycemic control, smoking cessation, and patient education.
Abstract:
Chronic limb-threatening ischaemia (CLTI) is a severe form of peripheral arterial disease (PAD) and is associated with an increased risk of amputation, mortality, and significantly impaired quality of life. International guidelines recommend considering timely revascularisation and optimal medical therapy to improve limb perfusion in individuals with CLTI. The 2 primary revascularization approaches for CLTI are open bypass surgery (BS) and endovascular therapy (EV), however, there is currently no consensus on the best initial treatment strategy for CLTI, leading to uncertainty among clinicians. To shed light on this issue, 2 recent trials, namely best endovascular versus best surgical therapy in patients with CLI (BEST-CLI) and bypass versus angioplasty for severe ischaemia of the leg (BASIL-2), have tried to provide valuable insights. While a definitive conclusion on the optimal revascularisation approach is still pending, these trials offer immediate and clinically relevant information to the diabetic foot multidisciplinary team. The trials encompassed a distinct range of patient cohorts and included participants with varying degrees of medical and physical frailty. Taken together, their findings, highlight the need for an individualised revascularisation strategy which accounts for underlying comorbidities, risk factors, disease severity, availability of suitable bypass conduits, surgical risks, and timely access to procedures. Regardless of the chosen strategy, early referral of patients with diabetes and CLTI to a specialist team within a multidisciplinary environment is crucial. Comprehensive care should encompass essential elements such as adequate debridement, infection control, offloading, glycaemic control, smoking cessation, and patient education. By addressing these aspects, healthcare providers can optimise the management and outcomes for individuals with CLTI and diabetes.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management

